Mangoceuticals, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE 13G: Greenfield Investments and Peter M. Karam Disclose Significant Stake in Mangoceuticals, Inc.
Greenfield Investments, Ltd and Peter M. Karam have jointly disclosed a beneficial ownership of 14.44% in Mangoceuticals, Inc.'s common stock, totaling 515,000 shares.